To: | APEX BIOTECHNOLOGY CORPORATION (mail@iphorgan.com) |
Subject: | U.S. Trademark Application Serial No. 88590882 - APEXBIO - SAI 0249 US |
Sent: | January 17, 2020 05:15:26 PM |
Sent As: | ecom127@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88590882
Mark: APEXBIO
|
|
Correspondence Address: |
|
Applicant: APEX BIOTECHNOLOGY CORPORATION
|
|
Reference/Docket No. SAI 0249 US
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: January 17, 2020
Application has been amended as shown below. As agreed to by John Bathke on January 17, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods are not permitted. 37 C.F.R. §2.71(a).
IDENTIFICATION OF GOODS AMENDED: The identification of goods in International Class 10 is amended to read as provided below. The identification of goods in International Class 5 remains without a change.
Class 10: Testing and analytical apparatus for medical diagnostic use in the field of blood biochemistry; testing and analytical apparatus for medical diagnostic use in the field of urine biochemistry; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic use
See TMEP §§1402.01, 1402.01(e).
/Maryna K. Gipsov/
Maryna K. Gipsov
Trademark Examining Attorney
Law Office 127
571-270-7630
maryna.koberidze@uspto.gov